Pointing index posture in progressive supranuclear palsy and corticobasal syndrome

Pointing index posture in progressive supranuclear palsy and corticobasal syndrome

Saved in:

Bibliographic Details
Main Authors:	Jacky Ganguly, Soumava Mukherjee, Nilam Singh, Hrishikesh Kumar
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-01-01
Series:	Annals of Movement Disorders
Online Access:	https://doi.org/10.4103/aomd.aomd_57_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Overlapping MRI findings in progressive supranuclear palsy ? corticobasal syndrome
by: Eduardo Della Valle Prezzi, et al.

Progressive supranuclear palsy and corticobasal degeneration: novel clinical concepts and advances in biomarkers
by: Jacy Bezerra Parmera, et al.
Published: (2022-08-01)

Differentiating Progressive Supranuclear Palsy and Corticobasal Syndrome: Insights from Cerebrospinal Fluid Biomarkers—A Narrative Review
by: Alexandros Giannakis, et al.
Published: (2025-04-01)

Prospective longitudinal cohort of Argentinean patients with progressive supranuclear palsy and corticobasal syndrome: A platform for epidemiological and translational research
by: Maria Jose Angel, et al.
Published: (2025-01-01)

Amantadine-induced corneal edema – A reversible cause of visual blurring in Parkinson’s disease
by: Jacky Ganguly, et al.
Published: (2025-01-01)

Palmaris brevis spasm syndrome: The treatable hypothenar dimpling
by: Jacky Ganguly, et al.
Published: (2024-05-01)

Head posture control under perturbed conditions in progressive supranuclear palsy patients
by: Vittorio Lippi, et al.
Published: (2025-05-01)

Zolpidem in Progressive Supranuclear Palsy
by: Sandip K. Dash
Published: (2013-01-01)

Progressive supranuclear palsy: new concepts
by: Orlando Graziani Povoas Barsottini, et al.
Published: (2010-12-01)

Progressive supranuclear palsy. Clinical and neuroimaging features
by: Paulo Eduardo Mestrinelli Carrilho
Published: (2001-09-01)

Word-Retrieval in Two Cases of Progressive Supranuclear Palsy
by: Jennifer M. Gurd, et al.
Published: (1997-01-01)

Emerging Hypersexuality in a Patient With Progressive Supranuclear Palsy
by: Pei Ling Lim, et al.
Published: (2025-06-01)

Frontotemporal Lobar degeneration with TDP-43 presenting as progressive supranuclear palsy syndrome
by: Aya Murakami, et al.
Published: (2025-07-01)

Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes with Progressive Supranuclear Palsy-like Manifestations
by: Naoki Yamahara, et al.
Published: (2024-10-01)

Paralisia supranuclear progressiva: aspectos pneumencefalograficos Progressive supranuclear palsy: pneumoencephalographic aspects. A case report
by: Alfredo Rizzo
Published: (1974-12-01)

Clinical features of supranuclear palsy
by: T. A. Valikova, et al.
Published: (2009-06-01)

Autonomic dysfunction in progressive supranuclear Palsy: A retrospective study
by: Yichun Wang, et al.
Published: (2025-01-01)

Functional connectivity abnormalities in clinical variants of progressive supranuclear palsy
by: Irene Sintini, et al.
Published: (2025-01-01)

Therapy of swallowing and speech problem in patients with progressive supranuclear palsy
by: Bunijevac Mila
Published: (2025-01-01)

Sensitivity and Specificity of the ECAS in Parkinson’s Disease and Progressive Supranuclear Palsy
by: Jennifer A. Foley, et al.
Published: (2018-01-01)

PET-CT imaging in a patient with progressive supranuclear palsy
by: Anderson Benine Belezia, et al.
Published: (2015-04-01)

Elementary motor perseveration in early diagnosis of progressive supranuclear palsy
by: Ricardo Nitrini
Published: (1987-03-01)

Investigation of the HLA locus in autopsy-confirmed progressive supranuclear palsy
by: Jinguo Wang, et al.
Published: (2025-05-01)

Progressive supranuclear palsy - like syndrome induced by amiodarone and flunarizine Paralisia supranuclear progressiva síndrome simile induzida por amiodarona e flunarizina
by: James Pitágoras de Mattos, et al.
Published: (2009-09-01)

Distinct sensorimotor cough features in a cohort of Progressive Supranuclear Palsy
by: Michela J. Mir, et al.
Published: (2025-01-01)

Diffusion tensor imaging of sequential neuropathological patterns in progressive supranuclear palsy
by: Lavinia A. Bârlescu, et al.
Published: (2025-06-01)

Validation of the Parkinson’s Disease Caregiver Burden Questionnaire in Progressive Supranuclear Palsy
by: Martin Klietz, et al.
Published: (2021-01-01)

<i>MAPT</i> Subhaplotypes in Different Progressive Supranuclear Palsy Phenotypes
by: Monica Gagliardi, et al.
Published: (2025-06-01)

Smaller and Denser Speech Graphs in Nondemented Patients with Progressive Supranuclear Palsy
by: Jinghong Ma, et al.
Published: (2023-01-01)

Clinical approach to probable mixed vascular dementia and progressive supranuclear palsy
by: Yetty Ramli
Published: (2024-09-01)

Serum Tau Species in Progressive Supranuclear Palsy: A Pilot Study
by: Costanza Maria Cristiani, et al.
Published: (2024-12-01)

Alzheimer’s Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy
by: Takanobu Ishiguro, et al.
Published: (2024-08-01)

Comparative study of nonmotor symptoms in progressive supranuclear palsy and Parkinson’s disease
by: Ying Chen, et al.
Published: (2025-05-01)

Schizophrenia and Atypical Motor Features in a Case of Progressive Supranuclear Palsy (The Steele-Richardson-Olszewski Syndrome)
by: F. Ovsiew, et al.
Published: (1993-01-01)

A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy.
by: Boyd C P Ghosh, et al.
Published: (2013-01-01)

Choroid plexus enlargement correlates with subcortical tau deposition in progressive supranuclear palsy
by: Na Wang, et al.
Published: (2025-05-01)

Montreal cognitive assessment as a cognitive outcome measure in progressive supranuclear palsy
by: Vanessa Ibrahim, et al.
Published: (2024-12-01)

Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UK
by: Robert Durcan, et al.
Published: (2025-07-01)

The Cognitive Profile and Executive Function of Progressive Supranuclear Palsy and Multiple System Atrophy Patients
by: Divya Goel, et al.
Published: (2019-04-01)

Trial of Zolpidem, Eszopiclone, and Other GABA Agonists in a Patient with Progressive Supranuclear Palsy
by: Andrew Young Chang, et al.
Published: (2014-01-01)